Navigation Links
Immunicon Will Exhibit CellCapture CTC Mouse/Rat Kit and EasyCount,System for Automated Cell Counting at AACR

ery early drug studies and may streamline this important phase of drug development. The CellCapture CTC Mouse Kit and CellTracks Analyzer II will be sold by the Immunicon sales team directly.

The EasyCount System is a fluorescent microscopy-based imaging system that accurately counts dead and live nucleated cells and automatically calculates cell viability, in a single test. Currently, most cell counting procedures are done manually using a hemacytometer and a microscope, which is a time-consuming and tedious process. The EasyCount System together with the EasyCount ViaSure(TM) Kit automate this routine function, eliminating the variability associated with the subjective interpretation of manual methods. The researcher can perform up to six tests at a time using the EasyCount Slide6(TM) Multi-Well Slide provided with the EasyCount ViaSure Kit and the instrument reports total and live cell counts and viability calculation in less than one minute per test. Immunicon will target research laboratories and industrial accounts including bioprocessing facilities in the pharmaceutical, biotechnology and diagnostics sectors, where rapid, accurate cell counting is valued highly by users.

About Immunicon Corporation

Immunicon Corporation is developing and commercializing proprietary cell- and molecular-based human diagnostic and life science research products, and is providing certain analytical services to pharmaceutical and biotechnology companies to assist them in developing new therapeutic agents, with an initial focus on cancer disease management. Immunicon has developed platform technologies to identify, count and characterize a small number of rare cells in blood, such as circulating tumor cells and circulating endothelial cells that are important in many diseases and biological processes. Immunicon's products and underlying technology platforms also have application in cancer research and may have applications in other fields of medicine, such as c
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Peer Reviewed Journal Article Indicates Repros Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer
2. ANA380 Exhibits Activity In Vitro Against Multiple Clinically Relevant Hepatitis B Virus Mutants

Post Your Comments:
(Date:11/6/2009)..., Mass., Nov. 6 DUSA Pha...rmatology company that is developing and marketing...her products focused on patients with common skin ...d Chief Executive Officer, will present a corporat...mmit 2009 on Tuesday, November 10, 2009 at 10:00 a...
(Date:11/6/2009)...N.Y., Nov. 6 Repossessions and liq...in the third quarter of 2009 declined as compared ...Asset Management,s NasTrac Quarterly Index (NQI). ...eports for both repossessions and orderly liquidat...oth construction and printing equipment, offering ...
(Date:11/6/2009)..., Nov. 6 America,s Spec...ing group of mid-market and smaller innovator phar...ut H.R. 3962, the "Affordable Health Care for Amer...day. These smaller companies fear that the cumula...ill hinder their efforts to bring new medicines to...
Breaking Medicine Technology:NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 2NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 3NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 4Statement of America's Specialty Medicines Companies On House Health Care Bill (H.R. 3962) 2Studies shed light on preserving fertility among cancer patients 52138 1Studies shed light on preserving fertility among cancer patients 52138 2New drug candidate prolongs the lives of pancreatic cancer patients 52135 1New drug candidate prolongs the lives of pancreatic cancer patients 52135 2Penn Wistar team gains insight into HIV vaccine failure 9292 1Penn Wistar team gains insight into HIV vaccine failure 9292 2
(Date:11/8/2009)...Newswire-USNewswire/ -- The following was released...e Insurrecta Nex. ,, Mr. Terry and his associa...keep child-killing by abortion out of any health c... is a great first step to victory -- a touchdown i...ng ahead of us. Our rejoicing must be tempered by ...
(Date:11/8/2009)...s Who Sides With Working Families vs. Insurance Co...-USNewswire/ -- On the heels of an historic late n...od, balanced health care reform bill, the Pennsylv...,s U.S. representatives voted on HR 3962, the Affo...islation, which passed Saturday evening by a vote ...
(Date:11/8/2009).... 8 March of Dimes host...n to recognize prominent individuals who are celeb...e models for March of Dimes commitment to improve ...es November Prematurity Awareness Month campaign, ...the fight for preemies! ,, (Photo: http://www...
(Date:11/7/2009)... Speaker Nancy Pelosi s...962, the Affordable Health Care for America Act. ...ht. Below are the Speaker,s remarks. ,, "Mada...oment for our nation and for American families. F...litical philosophy -- as far back as Teddy Rooseve...
(Date:11/7/2009)...swire-USNewswire/ -- The American Medical Associat...f Health at the Family Violence Prevention Fund, w...t its semi-annual policy-making meeting. The Cita...r the AMA House of Delegates bestows on a non-phys...i-bin/prnh/20081209/AMALOGO ) ,, "Ms. James h...
Breaking Medicine News(10 mins):Health News:Robert Brady (D-PA-1), Chaka Fattah (D-PA-2), Kathy Dahlkemper (D-PA-3), Joe Sestak (D-PA-7), Patrick Murphy (D-PA-8), Christopher Carney (D-PA-10), John Murtha (D-PA-12), Paul Kanjorski (D-PA-11), Allyson Schwartz (D-PA-13), Mike Doyle (D-PA-14) Ge 2Health News:Hollywood Stars Joined in a Celebration of Babies 2Health News:Hollywood Stars Joined in a Celebration of Babies 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 2Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 4Health News:AMA Honors Family Violence Prevention Expert 2
...Minn., March 26 Pharmacy benefit manager Prime Th...nical pharmacists, Patrick Gleason, PharmD, FCCP, ...armD were awarded the Journal of Managed Care Phar...laims data indicating risk for an adverse cardiova...
... Provide Strategic Direction and Execute Creative ...ermanente has chosen Digitas, Advertising Age,s ...toB Magazine,s 2008 Top Agency, as its online cre...cessful "Thrive" advertising campaign that the hea...
...Inspired Features and a Redesigned Interface, Onco... March 26 Compendia Bioscience announces the rele...latest incarnation of the company,s flagship produ...improve results of cancer drug development efforts...
...THICUM, Md., March 26 The statement below is att...ican Urological Association. This statement is bei...ished in the New England Journal of Medicine a...studies about prostate-specific antigen (PSA) test...
...cent of Surveyed MCO Pharmacy Directors Say They W...r Juvenile Idiopathic Arthritis and Pediatric Croh...on Resources , , WALTHAM, Mass., March 26 Decisi...atologists have altered their prescription pattern...
...ants weaken lungs, defenses against free radicals,...ealthDay News) -- Variations in several genes can ...well as how vulnerable they are to secondhand smok...al exposures such as tobacco smoke and air polluta...
Other Medicine News:Health News:Prime Pharmacists Recognized by the Journal of Managed Care Pharmacy 2Health News:Kaiser Permanente Names Digitas Agency of Record for Direct Marketing 2Health News:Kaiser Permanente Names Digitas Agency of Record for Direct Marketing 3Health News:Compendia Bioscience Releases Oncomine Concepts Edition 4.0 2Health News:Compendia Bioscience Releases Oncomine Concepts Edition 4.0 3Health News:American Urological Association Statement in Support of Prostate-Specific Antigen Testing 2Health News:American Urological Association Statement in Support of Prostate-Specific Antigen Testing 3Health News:As a Result of the FDA Investigation Into TNF-Alpha Inhibitors, 30 Percent of Surveyed Rheumatologists Have Altered Their Prescription Patterns for Juvenile Idiopathic Arthritis 2Health News:As a Result of the FDA Investigation Into TNF-Alpha Inhibitors, 30 Percent of Surveyed Rheumatologists Have Altered Their Prescription Patterns for Juvenile Idiopathic Arthritis 3Health News:Genes May Boost Harm to Kids From Secondhand Smoke 2
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
Medicine Products: